Cargando…
Circulating Interlukin-32 and Altered Blood Pressure Control in Individuals with Metabolic Dysfunction
Fatty liver disease is most frequently related to metabolic dysfunction (MAFLD) and associated comorbidities, heightening the risk of cardiovascular disease, and is associated with higher hepatic production of IL32, a cytokine linked with lipotoxicity and endothelial activation. The aim of this stud...
Autores principales: | Tomasi, Melissa, Cherubini, Alessandro, Pelusi, Serena, Margarita, Sara, Bianco, Cristiana, Malvestiti, Francesco, Miano, Lorenzo, Romeo, Stefano, Prati, Daniele, Valenti, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138906/ https://www.ncbi.nlm.nih.gov/pubmed/37108628 http://dx.doi.org/10.3390/ijms24087465 |
Ejemplares similares
-
Validation of a targeted gene panel sequencing for the diagnosis of hereditary chronic liver diseases
por: Ronzoni, Luisa, et al.
Publicado: (2023) -
Clinical and genetic determinants of the fatty liver–coagulation balance interplay in individuals with metabolic dysfunction
por: Valenti, Luca, et al.
Publicado: (2022) -
Trends and risk factors of SARS‐CoV‐2 infection in asymptomatic blood donors
por: Valenti, Luca, et al.
Publicado: (2021) -
Liver Involvement in Patients with Rare MBOAT7 Variants and Intellectual Disability: A Case Report and Literature Review
por: Ronzoni, Luisa, et al.
Publicado: (2023) -
Definition of Healthy Ranges for Alanine Aminotransferase Levels: A 2021 Update
por: Valenti, Luca, et al.
Publicado: (2021)